Jitendra Wadhane - 26 Mar 2024 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
SVP, Chief Accounting Officer
Signature
/s/ Jitendra Wadhane
Issuer symbol
PYXS
Transactions as of
26 Mar 2024
Net transactions value
$0
Form type
4
Filing time
28 Mar 2024, 16:31:43 UTC
Previous filing
17 Nov 2023
Next filing
23 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Award $0 +131,484 +49% $0.000000 398,421 26 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest 25% on the first anniversary of March 26, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.